NCT00003577View on ClinicalTrials.gov

Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer

PHASE3CompletedINTERVENTIONAL

Enrollment

2,000

Participants

Timeline

Start Date

March 31, 1996

Study Completion Date

September 30, 2008

Conditions

Breast Cancer

Interventions

DRUG

CMF regimen

DRUG

cyclophosphamide

DRUG

epirubicin hydrochloride

DRUG

fluorouracil

DRUG

methotrexate

PROCEDURE

adjuvant therapy

RADIATION

radiation therapy

Trial Locations (1)

CB2 2QQ

University of Cambridge, Cambridge

All Listed Sponsors

lead

University Hospital Birmingham

OTHER

NCT00003577 - Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer | Biotech Hunter | Biotech Hunter